Depression: An Important Comorbidity With Metabolic Syndrome in a General Population
Open accessThe DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—There is a recognized association among depression, diabetes, and cardiovascular disease. The aim of this study was to examine in a sample representative of the general population whether depression, anxiety, and psychological distress are associated with metabolic syndrome and its components. RESEARCH DESIGN AND METHODS—Three cross-sectional surveys including clinical health measures were completed in rural regions of Australia during 2004–2006. A stratified random sample (n = 1,690, response rate 48%) of men and women aged 25–84 years was selected from the electoral roll. Metabolic syndrome was defined by the Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Adult Treatment Panel III (NCEP ATP III), and International Diabetes Federation (IDF) criteria. Anxiety and depression were assessed by the Hospital Anxiety and Depression Scale and psychological distress by the Kessler 10 measure. RESULTS—Metabolic syndrome was associated with depression but not psychological distress or anxiety. Participants with the metabolic syndrome had higher scores for depression (n = 409, mean score 3.41, 95% CI 3.12–3.70) than individuals without the metabolic syndrome (n = 936, mean 2.95, 95% CI 2.76–3.13). This association was also present in 338 participants with the metabolic syndrome and without diabetes (mean score 3.37, 95% CI 3.06–3.68). Large waist circumference and low HDL cholesterol showed significant and independent associations with depression. CONCLUSIONS—Our results show an association between metabolic syndrome and depression in a heterogeneous sample. The presence of depression in individuals with the metabolic syndrome has implications for clinical management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Metabolic dysfunction is another common consequence of chronic stress in both humans and animals, with significant co-morbidity existing between MDD and metabolic syndrome112.”
From Central regulation of stress-evoked peripheral immune responses (2023) · cites this paper as [112]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The presence of MDD is a risk factor for a variety of complications, including neurodegenerative diseases (such as dementia, Alzheimer’s disease, and Parkinson’s disease), cardiovascular diseases (such as ischemic coronary artery disease and myocardial infarction), metabolic and endocrine diseases (such as obesity in females and diabetes in males), and some autoimmune diseases. 42 , 43”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [43]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518 · cited 1×
“This dysregulation of the HPA axis promotes deposition of visceral adipose tissue (6), which secretes inflammatory cytokines such as interleukin (IL)-1 and IL-6 and tumor necrosis factor (TNF)- (19,20).”
BackgroundXu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Alberti, K. G. M. M., Zimmet, P., & Shaw, J. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01858.x · Cited by 6,597 · cited 8×
“Second, the International Diabetes Federation (IDF) (2) criteria specify central obesity with a waist circumference 94 cm for men and 80 cm for women of Europid origin, plus two or more of the following: fasting plasma glucose 5.6 mmol/l or previously diagnosed type 2 diabetes; systolic blood pressure 130 mmHg, diasto…”
BackgroundMethodResultInfluentialBanting lecture 1988. Role of insulin resistance in human disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diabetes.37.12.1595 · Cited by 3,811 · cited 1×
“Both IL-6 and TNF- have been implicated in insulin resistance, which is considered to be the key factor in the metabolic abnormalities (21) of the metabolic syndrome.”
BackgroundThe Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579 · cited 1×
“Dysregulation of the HPA axis can occur via cytokine-induced stimulation of the central noradrenergic stress system (24).”
BackgroundInterpreting scores on the Kessler Psychological Distress Scale (K10)
Andrews, G., & Slade, T. (2001) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1467-842x.2001.tb00310.x · Cited by 2,021 · cited 3×
“For 1,345 men and women aged 25–84 years, information was available for the metabolic syndrome, HADS-D, HADS-A, K10, smoking status, alcohol intake, and physical activity (Ta- ble 2).”
MethodInfluential
Cited by
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,244
“42,43 The relationship between the onset of MDD and several diseases is complex and potentially bidirectional in nature.”
BackgroundPenninx, B. W., Milaneschi, Y., Lamers, F., & Vogelzangs, N. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-129 · Cited by 839
“The most consistent evidence exists for depression and obesity-related components (abdominal obesity, low HDL cholesterol, hypertriglyceridemia) [23-52].”
BackgroundAdult mental health outcomes of adolescent depression: A systematic review
Johnson, D., Dupuis, G., Piche, J., Clayborne, Z., & Colman, I. (2018) · Depression and Anxiety · doi:10.1002/da.22777 · Cited by 563
Functional Biomarkers of Depression: Diagnosis, Treatment, and Pathophysiology
Schmidt, H. D., Shelton, R. C., & Duman, R. S. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.151 · Cited by 474
“Furthermore, there is a high incidence of comorbid or coincident diseases, including Type-2 diabetes and MDD (Katon, 2008), as well as strong associations between MDD and metabolic syndrome (Dunbar et al, 2008).”
BackgroundDomenici, E., Willé, D. R., Tozzi, F., Prokopenko, I., Miller, S., McKeown, A., Brittain, C., Rujescu, D., Giegling, I., Turck, C. W., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009166 · Cited by 347
“The high comorbidity between type 2 diabetes and depression [18] and the strong association between depression and metabolic syndrome [19] are further justifications to support the above hypothesis.”
ResultAir Pollution, Stress, and Allostatic Load: Linking Systemic and Central Nervous System Impacts
Thomson, E. M. (2019) · Journal of Alzheimer’s Disease · doi:10.3233/jad-190015 · Cited by 290
Khuwaja, A. K., Lalani, S., Dhanani, R., Azam, I. S., Rafique, G., & White, F. (2010) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-2-72 · Cited by 253
“Studies on the association between Metabolic Syndrome (MetS) with anxiety and depression have reported inconsistent and conflicting findings [18-20].”
BackgroundResultCentral and Peripheral Inflammation Link Metabolic Syndrome and Major Depressive Disorder
Chan, K. L., Cathomas, F., & Russo, S. J. (2019) · Physiology · doi:10.1152/physiol.00047.2018 · Cited by 227
“nificant and independent correlations (33).”
Zhao, G., Ford, E. S., Li, C., Tsai, J., Dhingra, S., & Balluz, L. S. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-130 · Cited by 214
“Whether or not BMI should be included as a covariate in studies like ours or in studies dealing with metabolic syndrome [39-43] remains controversial at present.”
BackgroundMethodInfluentialCentral regulation of stress-evoked peripheral immune responses
Chan, K. L., Poller, W. C., Swirski, F. K., & Russo, S. J. (2023) · Nature Reviews Neuroscience · doi:10.1038/s41583-023-00729-2 · Cited by 207
Van Reedt Dortland, A. K. B., Giltay, E. J., Van Veen, T., Zitman, F. G., & Penninx, B. W. J. H. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01565.x · Cited by 191
“In studies considering the MetSyn and its components, mainly abdominal obesity (7–9, 13, 14, 17, 18, 20, 21, 25, 27), hypertriglyceridemia (7, 8, 11, 14, 21, 27, 28, 30) and a low HDL cholesterol (7, 9, 11, 13, 14, 25, 27, 31) were found to be associated with depressive symptoms, while associations with hypertension (…”
BackgroundDonoso, F., Cryan, J. F., Olavarría‐Ramírez, L., Nolan, Y. M., & Clarke, G. (2023) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2581 · Cited by 142
Thomas, M. J., Whittle, R., Menz, H. B., Rathod‐Mistry, T., Marshall, M. B., & Roddy, E. (2019) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-019-2718-6 · Cited by 152
“6), HADS anxiety and depression, categorised into normal (0–7), mild (8–10), moderate (11–14) and severe (15–21) [31], BMI calculated from self-reported height and weight (reference category < 25 kg/m(2)), selfreported lifetime recall of frequent high-heeled footwear use among females [18] (high frequency defined as r…”
BackgroundGheshlagh, R. G., Parizad, N., & Sayehmiri, K. (2016) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.26523 · Cited by 146
“Depression can activate the hypothalamus-pituitary-adrenal axis and by increasing the release of hydro-corticotrophin, adrenocorticotropic and cortisol hormones lead to the depositing of visceral adipose tissue (27).”
BackgroundInfluentialGiltay, E. J., Tishova, Y. A., Mskhalaya, G. J., Gooren, L. J. G., Saad, F., & Kalinchenko, S. Y. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01859.x · Cited by 140
Xu, Q., Anderson, D., & Lurie-Beck, J. (2011) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2011.04.007 · Cited by 136
The impact of stress systems and lifestyle on dyslipidemia and obesity in anxiety and depression
Dortland, A. K. B. V. R., Vreeburg, S. A., Giltay, E. J., Licht, C. M. M., Vogelzangs, N., van Veen, T., de Geus, E. J. C., Penninx, B. W. J. H., & Zitman, F. G. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.05.017 · Cited by 135
“, high total, low-density lipoprotein [LDL] cholesterol or triglycerides, or low high-density lipoprotein [HDL] cholesterol) and (abdominal) obesity are found to be more common in patients with anxiety disorders and depression (Gil et al., 2006; Skilton et al., 2007; Vogelzangs et al., 2007; Dunbar et al., 2008; Kopon…”
Comorbid Major Depressive Disorder in Schizophrenia: A Systematic Review and Meta-Analysis
Etchecopar‐Etchart, D., Korchia, T., Loundou, A., Llorca, P., Auquier, P., Lançon, C., Boyer, L., & Fond, G. B. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa153 · Cited by 134
Serious psychological distress and diabetes: a review of the literature
Egede, L. E., & Dismuke, C. E. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-011-0240-0 · Cited by 125
“Finally, among Australians aged 25 to 84 years diagnosed with metabolic syndrome in 2004 and observed until 2006, metabolic syndrome was not found to be associated with the K10 measure of SPD [64].”
BackgroundA review on linking stress, depression, and insulin resistance via low-grade chronic inflammation
Mehdi, S., Wani, S. U. D., Krishna, K. L., Kinattingal, N., & Roohi, T. F. (2023) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2023.101571 · Cited by 125
“Depression, interlinked to the MS, upregulates the secretion of hydrocorticotropin, adrenocorticotropic, and cortisol hormones by triggering the HPA axis, resulting in visceral adipose tissue accumulation [27].”
BackgroundUtge, S. J., Soronen, P., Loukola, A., Kronholm, E., Ollila, H. M., Pirkola, S., Porkka-Heiskanen, T., Partonen, T., & Paunio, T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009259 · Cited by 109
“Thus, these findings may offer one possible molecular mechanism for the association between metabolic syndrome and depressive disorders in general population [70,71].”
BackgroundMommersteeg, P. M. C., Kupper, N. H. M., & Denollet, J. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-714 · Cited by 118
“An Australian study examined the association between depression and metabolic syndrome in the general population and found that metabolic syndrome was related to higher depression scores, but not anxiety or psychological distress [40].”
BackgroundThe Association of Metabolic Syndrome and Urolithiasis
Wong, Y. V., Cook, P. R., & Somani, B. K. (2015) · International Journal of Endocrinology · doi:10.1155/2015/570674 · Cited by 118
Generalized Anxiety Disorder Is Associated with Metabolic Syndrome in the Vietnam Experience Study
Carroll, D., Phillips, A. C., Thomas, G. N., Gale, C. R., Deary, I., & Batty, G. D. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.02.020 · Cited by 104
Tang, F., Wang, G., & Lian, Y. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.11.025 · Cited by 117
Longitudinal Relationship of Depressive and Anxiety Symptoms With Dyslipidemia and Abdominal Obesity
van Reedt Dortland, A. K. B., Giltay, E. J., van Veen, T., Zitman, F. G., & Penninx, B. W. J. H. (2013) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318274d30f · Cited by 100
Ribeiro, R. P., Marziale, M. H. P., Martins, J. T., Ribeiro, P. H. V., Robazzi, M. L. D. C. C., & Dalmas, J. C. (2015) · Revista Latino-Americana de Enfermagem · doi:10.1590/0104-1169.0383.2573 · Cited by 114
“A study undertaken in Australia, with the objective of identifying, in the population in general, the relationship between diabetes, depression and cardiovascular disease, and which used the same instrument for verification as the present study, the HADS, ascertained that MetS has a significant correlation with depres…”
MethodKahl, K. G., Schweiger, U., Correll, C., Müller, C., Busch, M., Bauer, M., & Schwarz, P. (2015) · Brain and Behavior · doi:10.1002/brb3.306 · Cited by 89
“Cross-sectional studies examining the association between depression, anxiety, and the MetS yielded conflicting results, either pointing to a general association (Heiskanen et al. 2006; Skilton et al. 2007; Dunbar et al. 2008; Miettola et al. 2008; Heppner et al. 2009; Kahl et al. 2012; Pan et al. 2012; Vancampfort et…”
ResultHigh-fat diet causes psychiatric disorders in mice by increasing Proteobacteria population
Jeong, M.-Y., Jang, H.-M., & Kim, D.-H. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.01.006 · Cited by 110
Psychological distress in Ghana: associations with employment and lost productivity
Canavan, M., Sipsma, H. L., Adhvaryu, A. R., Ofori-Atta, A. L., Jack, H. E., Udry, C., Osei‐Akoto, I., & Bradley, E. H. (2013) · International Journal of Mental Health Systems · doi:10.1186/1752-4458-7-9 · Cited by 109
“For analysis, we created 3 categories based on scores consistent with K10 categories in previous studies [16,17]: 10–24, indicating likely to be well or have mild psychological distress; 25–29 for likely to have moderate psychological distress; and 30–50 for likely to have severe psychological distress.”
MethodDécarie-Spain, L., Sharma, S., Hryhorczuk, C., Issa-Garcia, V., Barker, P. A., Arbour, N., Alquier, T., & Fulton, S. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.01.018 · Cited by 107
Vogelzangs, N., Beekman, A. T. F., Boelhouwer, I. G., Bandinelli, S., Milaneschi, Y., Ferrucci, L., & Penninx, B. W. J. H. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06559 · Cited by 100
The Metabolic Syndrome, a Human Disease
Alemany, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042251 · Cited by 101
Brand, S., Moller, M., & Harvey, B. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150307004545 · Cited by 95
“The increased comorbidity between type 2 diabetes and MD [512] and the strong link between MD and metabolic syndrome [513] further supports this hypothesis.”
BackgroundMoradi, Y., Albatineh, A. N., Mahmoodi, H., & Gheshlagh, R. G. (2021) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-021-00117-8 · Cited by 93
“can activate the hypothalamic–pituitary–adrenal axis and lead to accumulation of visceral fat through increasing the secretion of corticotrophin-releasing hormone, adrenocorticotropic hormone, and cortisol [50].”
BackgroundIdentification of depression in diabetes: the efficacy of PHQ-9 and HADS-D
Reddy, P., Philpot, B., Ford, D., & Dunbar, J. A. (2010) · British Journal of General Practice · doi:10.3399/bjgp10x502128 · Cited by 90
Self-citationDepression and Metabolic Syndrome: A Narrative Review
Al-Khatib, Y., Akhtar, M. A., Kanawati, M. A., Mucheke, R., Mahfouz, M., & Al-Nufoury, M. (2022) · Cureus · doi:10.7759/cureus.22153 · Cited by 89
“In the last decade, a lot of research has been done to elucidate the relationship between depression and metabolic syndrome, and most of the studies have found a positive association [6-16].”
BackgroundNunn, A. V., Bell, J. D., & Guy, G. W. (2009) · Nutrition & Metabolism · doi:10.1186/1743-7075-6-16 · Cited by 75
“The tipping point could have a profound influence on life expectancy, which in humans is largely (but not exclusively), determined by cardiovascular disease: the metabolic syndrome is associated with an earlier than normal onset of many diseases, including renal disease, cancer, osteoporosis, depression and neurodegen…”
Lu, M., Yang, J.-Z., Geng, F., Ding, J.-H., & Hu, G. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000285 · Cited by 79
“In addition to the decreased neurogenesis, epidemiological studies show that patients with major depression are associated with a higher risk of metabolic syndrome and activated inflammatory pathways (Dunbar et al., 2008).”
BackgroundFontana, A., Manchia, M., Panebianco, C., Paribello, P., Arzedi, C., Cossu, E., Garzilli, M., Montis, M. A., Mura, A., Pisanu, C., et al. (2020) · Biomedicines · doi:10.3390/biomedicines8090311 · Cited by 84
“Supporting this link are the observations that MDD patients often exhibit metabolic and gastrointestinal symptoms [29,31] and that some antidepressants exhibit antimicrobial properties, while some antibiotics produce antidepressant effects [32].”
BackgroundBeyazyüz, M., Albayrak, Y., Eğilmez, O. B., Albayrak, N., & Beyazyüz, E. (2013) · Psychiatry Investigation · doi:10.4306/pi.2013.10.2.148 · Cited by 83
Saboya, P. M. H. P., Bodanese, L. C., Zimmermann, P. R., Gustavo, A. D. S., Macagnan, F. E., Feóli, A. M. P., & Oliveira, M. D. S. (2016) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20160186 · Cited by 83
Wu, H., Liu, Q., Kalavagunta, P. K., Huang, Q., Lv, W., An, X., Chen, H., Wang, T., Heriniaina, R. M., Qiao, T., et al. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-0140-z · Cited by 83
Depression and metabolic syndrome in the older population: A review of evidence
Repousi, N., Masana, M. F., Niubo, A. S., Haro, J. M., & Tyrovolas, S. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.102 · Cited by 83
“Indeed, abdominal obesity is often regarded as a key component of the MetS (Després et al., 2008; Després, 2006) and previous reports have suggested that it is the most important MetS feature in relation to depression (Dunbar et al., 2008; Takeuchi et al., 2009).”
BackgroundResultVascular endothelial growth factor: An important molecular target of curcumin
Saberi‐Karimian, M., Katsiki, N., Caraglia, M., Boccellino, M., Majeed, M. A., & Sahebkar, A. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1366892 · Cited by 81
“son, and MacDonald 2010), which has a history of long-term safety (Dunbar et al. 2008).”
BackgroundAre the recent secular increases in the waist circumference of adults independent of changes in BMI?
Freedman, D. S., & Ford, E. S. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.094672 · Cited by 70
“Several possible explanations were proposed for the observed trends inwaist circumference (20, 23), including changes in energy take, distribution of race-ethnicity, and prevalence of endocrine disruptors, physical activity, polycystic ovary syndrome (46), use of antiobesity treatments (47, 48), certain depressive sym…”
Major Depression and the Metabolic Syndrome
Foley, D. L., Morley, K. I., Madden, P. A. F., Heath, A. C., Whitfield, J. B., & Martin, N. G. (2010) · Twin Research and Human Genetics · doi:10.1375/twin.13.4.347 · Cited by 69
Bowles, N. P., Hill, M. N., Bhagat, S. M., Karatsoreos, I. N., Hillard, C. J., & McEwen, B. S. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.048 · Cited by 64
“This could be articularly relevant for the growing rise of comorbidity of ood and anxiety disorders with the increasing obesity pidemic (Dunbar et al., 2008; Chrousos and Kino, 2009; akeuchi et al., 2009).”
BackgroundColizzi, M., Costa, R., Scaramuzzi, F., Palumbo, C., Tyropani, M., Pace, V., Quagliarella, L., Brescia, F., Natilla, L. C., Loverro, G., et al. (2015) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2015.02.001 · Cited by 75
“sedentary behavior, sleep dysregulation, and increased appetite) [28,29], alterations of the hypothalamic–pituitary–adrenal axis (HPA) [30,31], vulnerability to a genotypic peculiar form of MetS [32–35] and direct action of antidepressant and antipsychotic drugs on lipid and carbohydratemetabolism [36–41].”
BackgroundPuustinen, P. J., Koponen, H., Kautiainen, H., Mäntyselkä, P. T., & Vanhala, M. J. (2010) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3182037315 · Cited by 75
Allostatic load and mental health: a latent class analysis of physiological dysregulation
Carbone, J. T. (2020) · Stress · doi:10.1080/10253890.2020.1813711 · Cited by 70
“…(Bob et al., 2010), combining immune and metabolic dysregulation may result in a clearer picture of common comorbidities as they relate to MDD. Specifically, obesity, diabetes, and metabolic syndrome are common MDD comorbidities (Anderson et al., 2001; Dunbar et al., 2008; Olvera et al., 2015).”
BackgroundThe common pathophysiology underlying the metabolic syndrome, schizophrenia and depression. A review
Kučerová, J., Babinská, Z., Horská, K., & Kotolová, H. (2014) · Biomedical Papers · doi:10.5507/bp.2014.060 · Cited by 66
Cutuli, D., Decandia, D., Giacovazzo, G., & Coccurello, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914686 · Cited by 64
“If depression is associated with metabolic diseases [236], and regular exercise is an anti-depressant factor for patients with major depression, and irisin is an exercise-dependent myokine showing an anti-depressant activity [224,225], then irisin can achieve its anti-depressant effects via the…”
BackgroundCognitive and affective functions in Alzheimer's disease patients with metabolic syndrome
Hishikawa, N., Fukui, Y., Sato, K., Kono, S., Yamashita, T., Ohta, Y., Deguchi, K., & Abe, K. (2015) · European Journal of Neurology · doi:10.1111/ene.12845 · Cited by 63
“In addition to cognitive dysfunction, those with AD also have abnormal affective functions, including depression and apathy, which may also be related to MetS [8,9].”
BackgroundBaygi, F., Herttua, K., Jensen, O. C., Djalalinia, S., Mahdavi Ghorabi, A., Asayesh, H., & Qorbani, M. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-0489-6 · Cited by 50
Wang, Q., Chair, S. Y., & Wong, E. M. L. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.12.084 · Cited by 61
Viscogliosi, G., Andreozzi, P., Chiriac, I. M., Cipriani, E., Servello, A., Marigliano, B., Ettorre, E., & Marigliano, V. (2013) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3817 · Cited by 51
“This finding is in accordance with previous reports documenting a higher prevalence of mood disorders in MetS patients (Skilton et al., 2007; Dunbar et al., 2008; Khuwaja et al., 2010).”
BackgroundResultOlvera, R. L., Williamson, D. E., Fisher‐Hoch, S. P., Vatcheva, K. P., & McCormick, J. B. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09118 · Cited by 58
Lasić, D., Bevanda, M., Bošnjak, N., Uglešić, B., Glavina, T., & Franić, T. (2014) · PubMed · Cited by 55
Polycystic Ovary Syndrome, Depression, and Affective Disorders
Bishop, S. C., Basch, S., & Futterweit, W. (2009) · Endocrine Practice · doi:10.4158/ep09083.rar · Cited by 47
Cardiovascular disease risk, awareness, and treatment in people with epilepsy
Terman, S. W., Aubert, C. E., Hill, C. E., Skvarce, J., Burke, J. F., & Mintzer, S. (2021) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2021.107878 · Cited by 53
“Participants also completed the Patient Health Questionnaire-9 (PHQ9) to evaluate depression at the time of the survey [27] which we include due to depression’s relationship with the metabolic syndrome [28,29].”
MethodNon-alcoholic fatty liver disease and its association with depression in Korean General Population
Jung, J. Y., Park, S. K., Oh, C.-M., Chung, P.-W., & Ryoo, J.-H. (2019) · Journal of Korean Medical Science · doi:10.3346/jkms.2019.34.e199 · Cited by 51
Frisbee, J. C., Wu, F., Goodwill, A. G., Butcher, J. T., & Beard, D. A. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00275.2011 · Cited by 49
“While there are multiple venues through which these conditions can impact public health, patient quality of life and mortality (13, 26), one of the most common is via an elevated risk for the development of peripheral vascular disease (PVD), which can generally be considered as an evolving condition, wherein the abili…”
BackgroundDepression and Its Comorbid Conditions More Serious in Women than in Men in the United States
Kim, W. K., Shin, D., & Song, W. O. (2015) · Journal of Women's Health · doi:10.1089/jwh.2014.4919 · Cited by 36
Thomson, E. M. (2013) · Endocrine Disruptors · doi:10.4161/endo.27489 · Cited by 47
Metabolic syndrome and central obesity in depression: A cross-sectional study
Garg, K., Agarwal, A., Agarwal, M., Dalal, P., Trivedi, J., & Srivastava, J. (2016) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.192021 · Cited by 45
“This has been reported in many of the studies.[24,37,41-44] Over the last 10–15 years, an increasing amount of literature has appeared, examining the cross-sectional and longitudinal relationship between the constructs of obesity and depression.”
ResultMetabolic Effects of Antidepressant Treatment
Olguner Eker, O., Ozsoy, S., Eker, B., & Dogan, H. (2017) · Nöro Psikiyatri Arşivi · doi:10.5152/npa.2016.12373 · Cited by 44
Evaluation of the effects of curcumin in patients with metabolic syndrome
Saberi‐Karimian, M., Parizadeh, S. M. R., Ghayour‐Mobarhan, M., Salahshooh, M. M., Dizaji, B. F., Safarian, H., Javandoost, A., Ferns, G. A., Sahebkar, A., & Ahmadinejad, M. (2018) · Comparative Clinical Pathology · doi:10.1007/s00580-017-2624-y · Cited by 44
“Curcumin has been shown to be well tolerated and safe in long-term studies (Dunbar et al. 2008) and is known to be safe up to dose of 10 g/day (Fakhrzadeh et al. 2006, Esmaillzadeh et al. 2006).”
BackgroundA review of brain insulin signaling in mood disorders: From biomarker to clinical target
Nguyen, T. T. L., Chan, L. C., Borreggine, K. L., Kale, R. P., Hu, C., & Tye, S. J. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.05.014 · Cited by 44
Klimek, P., Aichberger, S., & Thurner, S. (2016) · Scientific Reports · doi:10.1038/srep39658 · Cited by 44
“Indeed, depression has been identified as an important comorbidity of the metabolic syndrome in various cross-sectional surveys [8, 9].”
Pathophysiological basis of cardiovascular disease and depression: a chicken-and-egg dilemma
Paz-Filho, G., Licinio, J., & Wong, M. (2010) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462010000200015 · Cited by 42
Central Adiponectin Signaling – A Metabolic Regulator in Support of Brain Plasticity
Formolo, D. A., Cheng, T., Yu, J., Kranz, G. S., & Yau, S. (2022) · Brain Plasticity · doi:10.3233/bpl-220138 · Cited by 40
Hjellset, V. T., Ihlebæk, C., Bjørge, B., Eriksen, H. R., & Høstmark, A. T. (2010) · Journal of Immigrant and Minority Health · doi:10.1007/s10903-010-9409-6 · Cited by 40
“found to be better on depression than anxiety [44].”
BackgroundLi, Y., Liu, Y., Shen, J.-D., Chen, J., Pei, Y.-Y., & Fang, X. (2016) · Molecules · doi:10.3390/molecules21101341 · Cited by 40
“In fact, depression is a common comorbidity of metabolic syndrome [16,17] or Cushing syndrome [18,19].”
BackgroundBrumby, S. A., Chandrasekara, A., Kremer, P. J., Torres, S. J., McCoombe, S. G., & Lewandowski, P. A. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-1018 · Cited by 39
“Previous studies on chronic psychological distress [12] and our own preliminary cross sectional data analysis [9] have established links between physical activity and mental wellbeing.”
BackgroundCrichton, G. E., Elias, M. F., & Robbins, M. A. (2016) · BMC Public Health · doi:10.1186/s12889-016-3170-2 · Cited by 38
“Inflammation as a consequence of obesity is likely to be a central component [41, 46].”
Metabolic Syndrome Knowledge among Adults with Cardiometabolic Risk Factors: A Cross-Sectional Study
Wang, Q., Chair, S. Y., Wong, E. M. L., Taylor‐Piliae, R. E., Qiu, X., & Li, X. M. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16010159 · Cited by 37
Frisbee, J. C., Hollander, J. M., Brock, R. W., Yu, H., & Boegehold, M. A. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00096.2009 · Cited by 36
East, C. A., Willis, B. L., Barlow, C. E., Grannemann, B. D., FitzGerald, S. J., DeFina, L. F., & Trivedi, M. H. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0017 · Cited by 36
Sexuality and Psychopathological Aspects in Premenopausal Women with Metabolic Syndrome
Alvisi, S., Baldassarre, M., Lambertini, M., Martelli, V., Berra, M., Moscatiello, S., Marchesini, G., Venturoli, S., & Meriggiola, M. C. (2014) · The Journal of Sexual Medicine · doi:10.1111/jsm.12585 · Cited by 35
Ma, Y., Balasubramanian, R., Pagoto, S. L., Schneider, K. L., Hébert, J. R., Phillips, L. S., Goveas, J. S., Culver, A. L., Olendzki, B. C., Beck, J., et al. (2013) · American Journal of Public Health · doi:10.2105/ajph.2013.301394 · Cited by 29
Predictors of adherence in a prevention program for patients with metabolic syndrome
Susin, N., Boff, R. D. M., Ludwig, M. W. B., Feóli, A. M. P., da Silva, A. G., Macagnan, F. E., & Oliveira, M. D. S. (2015) · Journal of Health Psychology · doi:10.1177/1359105315572451 · Cited by 33
“It is important to consider the presence of these psychological aspects when dealing with patients with MetS, as well as other chronic conditions (Dunbar et al., 2008; Hudson et al., 2010).”
BackgroundClassifying depression using blood biomarkers: A large population study
Lin, Z., Lawrence, W. R., Huang, Y., Lin, Q., & Gao, Y. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.05.070 · Cited by 32
Pitsillou, E., Liang, J. J., Hung, A., & Karagiannis, T. C. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118809 · Cited by 31
Gaysina, D., Pierce, M. B., Richards, M., Hotopf, M. H., Kuh, D. J., & Hardy, R. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.01.019 · Cited by 31
“Fax: +44 sina). tion, however, has been paid to the association between anxiety and the metabolic syndrome, with the few existing cross-sectional studies reporting mixed findings (Carroll et al., 2009; Dunbar et al., 2008).”
Pan, Q., Liu, Q., Wan, R., Kalavagunta, P. K., Liu, L., Lv, W., Qiao, T., Shang, J., & Wu, H. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-0392-x · Cited by 31
Associations Among Depression, Obesity, and Metabolic Syndrome in Young Adult Females
Lin, K. P., Liang, T., Liao, I., & Tsay, S. L. (2013) · Biological Research For Nursing · doi:10.1177/1099800413500138 · Cited by 30
“These findings are consistent with the results of other recent studies (Dunbar et al., 2008; Kahl et al., 2005; Zhao et al., 2009) and add to the evidence that depression promotes weight gain and is an independent predictor of overweight and obesity.”
BackgroundResultInfluentialButnorienė, J., Steiblienė, V., Saudargienė, A., & Bunevičius, A. (2018) · BMC Psychiatry · doi:10.1186/s12888-017-1576-8 · Cited by 30
Chakraborti, A., Graham, C., Chehade, S. B., Vashi, B., Umfress, A., Kurup, P. K., Vickers, B. N., Chen, H. A., Telange, R., Berryhill, T. F., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.669410 · Cited by 30
Gurka, M. J., Vishnu, A., Okereke, O. I., Musani, S. K., Sims, M., & DeBoer, M. D. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.02.030 · Cited by 28
Lee, I. T., Rees, J., King, S., Kim, A. E., Cherlin, T., Hinkle, S. N., Mumford, S. L., & Dokras, A. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae256 · Cited by 28
Demirci, H., Çınar, Y., & Bilgel, N. (2011) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5350/kpb-bcp201121108 · Cited by 28
“The lack of association between fasting plasma glucose and depression is shown in many previous studies (1,7,9,11,37,39,40).”
BackgroundResultInfluentialEl Massry, M., Alaeddine, L. M., Ali, L., Saad, C., & Eid, A. A. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867327666200908114902 · Cited by 27
Baghdadi, L. R., Alhassan, M. K., Alotaibi, F. H., AlSelaim, K. B., Alzahrani, A. A., & AlMusaeed, F. F. (2021) · Journal of Primary Care & Community Health · doi:10.1177/21501327211054987 · Cited by 27
Taha, A. Y., Gao, F., Ramadan, E., Cheon, Y., Rapoport, S. I., & Kim, H. (2012) · BMC Neuroscience · doi:10.1186/1471-2202-13-131 · Cited by 27
“Disturbed brain AA and DHA metabolism has been linked to a number of neurodegenerative diseases, including Alzheimer’s disease and bipolar disorder [31-33], which are more common in individuals with the metabolic syndrome [4-8].”
BackgroundRubinow, D. R., & Girdler, S. S. (2011) · Depression and Anxiety · doi:10.1002/da.20833 · Cited by 27
“[156,157] In those at high metabolic risk, the prevalence of depression is increased by 50%.[158] Conversely, depression exerts adverse influences on the sympathetic and the HPA axes, which are implicated in the development of metabolic risk, particularly central adiposity and insulin resistance.”
BackgroundSilverstein‐Metzler, M. G., Shively, C. A., Clarkson, T. B., Appt, S. E., Carr, J. J., Kritchevsky, S. B., Jones, S. R., & Register, T. C. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.02.012 · Cited by 27
Block, A., Schipf, S., der Auwera, S. V., Hannemann, A., Nauck, M. A., John, U., Völzke, H., Freyberger, H. J., Dörr, M., Felix, S. B., et al. (2016) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2016.1191535 · Cited by 27
“In summary, a multiplicity of studies examined the putative association between MDD and MetS (15,18,19,35,36), but there are only few large population-based studies (n> 1000) that covered both sexes and the entire adult age range ( 30 years up to 65 years).”
BackgroundContemporary management of moderate to severe plaque psoriasis.
Wu, J. J. (2017) · PubMed · Cited by 27
Camacho‐Barcia, L., Munguía, L., Lucas, I., de la Torre, R., Salas‐Salvadó, J., Pintó, X., Corella, D., Granero, R., Jiménez‐Múrcia, S., Gonzalez-Monje, I., et al. (2021) · Nutrients · doi:10.3390/nu13082779 · Cited by 26
Metadata
- Authors
- Dunbar, J. A., Reddy, P., Davis-Lameloise, N., Philpot, B., Laatikainen, T., Kilkkinen, A., Bunker, S. J., Best, J. D., Vartiainen, E., Kai Lo, S., & Janus, E. D.
- Affiliations
- Deakin University (AU)
- Greater Green Triangle University Department of Rural Health, Flinders and Deakin Universities, Warrnambool, Victoria, Australia
- The University of Melbourne (AU)
- National Public Health Institute, Helsinki, Finland
- Faculty of Health Medicine Nursing and Behavioural Sciences, Deakin University, Melbourne, Victoria, Australia
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2008-12-01
- Volume
- 31
- Issue
- 12
- Pages
- 2368-2373
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2584197
- OpenAlex
- W2104386411
- Cited by
- 241
- References
- 30
- Citations by year
- 2026: 8 · 2025: 7 · 2024: 14 · 2023: 9 · 2022: 11 · 2021: 22 · 2020: 7 · 2019: 14 · 2018: 13 · 2017: 13 · 2016: 21 · 2015: 15 · 2014: 10 · 2013: 18 · 2012: 11
- FWCI
- 11.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Deakin Research Online (Deakin University) (submittedVersion)
- Flinders Academic Commons (Flinders University) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
- Funders
- Pfizer
- Sanofi
- Australian Government
- Royal Australian College of General Practitioners
- Servier
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- depression, metabolic syndrome, anxiety, psychological distress, waist circumference, HDL cholesterol, diabetes mellitus, cardiovascular disease, rural population
- MeSH terms
- Adult, Aged, Aged, 80 and over, Cross-Sectional Studies, Depression, Female, Humans, Male, Middle Aged, Comorbidity, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.